Patents Represented by Attorney John J. Kolano
  • Patent number: 4766212
    Abstract: Derivatives of 2H-[1]benzoxepino[5,4-b]-1,4-oxazine, such as trans-3,4,4a,5,6,11b-hexahydro-10-methoxy-2H-[1]benzoxepino[5,4-b]-1,4-oxa zine, are prepared by acylating a trans-4-amino-2,3,4,5-tetrahydro-1-benzoxepin-5-ol, cyclizing the resulting chloroacetamido alcohol, reducing the 1,4-oxazine-3(4H)-one so obtained, acylating the resulting 2H-[1]-benzoxepino[5,4-b]-1,4-oxazine, and reducing the N-acryl-2H-[1]benzoxepino[5,4-b]-1,4-oxazine so obtained. The novel compounds disclosed herein possess useful antihypertensive properties.
    Type: Grant
    Filed: October 29, 1987
    Date of Patent: August 23, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jules Freedman, Richard C. Dage
  • Patent number: 4761474
    Abstract: 3-(1H-Tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones useful as antiallergic agents are described herein. The compounds are prepared by cyclization of an appropriate substituted amidine using an alkali metal base. The reaction is carried out in an appropriate inert solvent.
    Type: Grant
    Filed: February 25, 1986
    Date of Patent: August 2, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shyam Sunder, Anna P. Vinogradoff
  • Patent number: 4757075
    Abstract: A method of reducing serum levels of uric acid which comprises administration of 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone or its pharmaceutically acceptable salts is described herein.
    Type: Grant
    Filed: October 14, 1986
    Date of Patent: July 12, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Steven R. Wagner
  • Patent number: 4748274
    Abstract: The present invention relates to compounds which are 4-hydroxy-4-alkenylcyclohexanecarboxylic acid derivatives possessing leukotriene antagonist activity. The compounds are useful in the treatment of allergic diseases, particularly in the treatment of human asthma. They are prepared by the reaction of an appropriate oxaspiro compound with a mercaptoalkanoic acid derivative.
    Type: Grant
    Filed: November 7, 1986
    Date of Patent: May 31, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Robert J. Cregge, Nelsen L. Lentz
  • Patent number: 4745222
    Abstract: This invention relates to aryloxycycloalkanolaminoalkylene aryl ketones to the processes for their preparation and to their use as antihypertensive agents.
    Type: Grant
    Filed: April 17, 1984
    Date of Patent: May 17, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Michael E. LeTourneau, James R. McCarthy, Donald L. Trepanier
  • Patent number: 4735948
    Abstract: (1H-Tetrazol-5-yl)-2(1H)-quinolones useful as antiallergic agents are described herein. The compounds are prepared by the reaction of sodium azide and ammonium chloride with an appropriate 3-cyano-2(1H)-quinolinone.
    Type: Grant
    Filed: March 25, 1983
    Date of Patent: April 5, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Wright
  • Patent number: 4734431
    Abstract: The present invention is directed to a group of compounds which are variously methylated thiopyranodipyrazoles and to the S-oxides and S-dioxides of such compounds. The compounds are useful as bronchodilators and are prepared by the reaction of appropriately 5-substituted thiopyrano[3,4-c]pyrazol-4-(1H)-one with a hydrazine.
    Type: Grant
    Filed: January 27, 1987
    Date of Patent: March 29, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Michael E. Le Tourneau, Norton P. Peet
  • Patent number: 4734430
    Abstract: A group of variously methyl-substituted[1,2-c:3,4-c']dipyrazoles, cyclohepta[1,2-c:3,4-c']dipyrazoles, and cyclopenta[1,2-c:3,4-c']dipyrazoles useful as bronchodilators are described herein. The compounds are prepared by reacting a 1,3-diketone with hydrazine or methylhydrazine to give tricyclic products optionally followed by catalytic dehydrogenation and/or alkylation with a strong base and methyl iodide to give various other compounds within the scope of the invention.
    Type: Grant
    Filed: January 27, 1987
    Date of Patent: March 29, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Michael E. Le Tourneau, Norton P. Peet
  • Patent number: 4734429
    Abstract: The present invention is directed to a group of methylated tetrahydro cyclohepta[1,2-c:4,3-c']dipyrazoles and benzo[1,2-c:4,3-c']dipyrazoles useful as bronchodilators. The compounds are prepared by the reaction of an appropriate hydrazine with an appropriate 1,3-diketone or with a compound that is chemically equivalent to a 1,3-diketone.
    Type: Grant
    Filed: January 27, 1987
    Date of Patent: March 29, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Michael E. Le Tourneau, Norton P. Peet
  • Patent number: 4703058
    Abstract: This invention relates to novel .beta.-methylenefuranethanamines which are mechanism-based inhibitors of dopamine beta-hydroxylase useful as antihypertensive agents.
    Type: Grant
    Filed: June 6, 1986
    Date of Patent: October 27, 1987
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Thomas M. Bargar, Robert Broersma, Jr., James R. McCarthy
  • Patent number: 4650872
    Abstract: 5-Chloro-3-(substituted)-s-triazolo[4,3-a]pyridine-7-carboxylic acids useful as antiallergic agents are described herein. The compounds are prepared from an appropriate acyl 6-chloro-2-hydrazinopyridine, substituted at the 4-position with a trichloromethyl group or a cyano group, by reaction with polyphosphoric acid.
    Type: Grant
    Filed: August 1, 1985
    Date of Patent: March 17, 1987
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Wright
  • Patent number: 4644065
    Abstract: A new process for the preparation of 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinones from anthranilic acid derivatives is described herein. Additional reactants used in the process are 4-aminotetrazole and a trialkoxymethane or the reaction can be carried out using the imidic ester obtained from these two compounds.
    Type: Grant
    Filed: May 15, 1984
    Date of Patent: February 17, 1987
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Anna P. Vinogradoff
  • Patent number: 4634765
    Abstract: Homonojirimycin glycosides active as inhibitors of carbohydrate digestive enzymes are described herein. The compounds are prepared by the reaction of an appropriately protected homonojirimycin with a protected glycosyl halide followed by removal of the protecting groups.
    Type: Grant
    Filed: December 18, 1984
    Date of Patent: January 6, 1987
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Paul S. Liu
  • Patent number: 4622422
    Abstract: The present invention is directed to 2-hydroxy-4-alkylidenecyclohexanealkanoic acids having a mercaptoalkanoic acid substituent at the 3-position. Esters and amides corresponding to the acids referred to above are also encompassed by the present invention. These compounds are useful in the treatment of bronchial asthma and they are obtained by the reaction of an appropriate 2,3-epoxy-4-alkylidenecyclohexanealkanoate with a mercapto alkanoic acid ester in the presence of a tertiary amine. The indicated process gives the esters of the present invention which can be hydrolyzed to the corresponding free acids by standard procedures. The compounds described can be subjected to other known reactions to give the other compounds of the present invention.
    Type: Grant
    Filed: August 23, 1985
    Date of Patent: November 11, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Robert J. Cregge, Jeffrey S. Sabol
  • Patent number: 4593099
    Abstract: (1H-Tetrazol-5-yl)thienopyridinones and related compounds which are useful as antiallergic agents are described herein. The compounds are prepared by the reaction of an appropriate cyanoketone with ammonium chloride and an azide such as sodium azide in an inert solvent such as dimethylformamide.
    Type: Grant
    Filed: October 10, 1984
    Date of Patent: June 3, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Wright
  • Patent number: 4588733
    Abstract: 2-Phenylpyrano[2,3-b]pyridines are described herein. These compounds are active against a variety of viruses. A number of procedures can be used to prepare the compounds of this invention but, at some point, they would all make use of the cyclization of a (phenyl) (pyridyl)propanol or (phenyl) (pyridyl)propenol.
    Type: Grant
    Filed: October 19, 1984
    Date of Patent: May 13, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Thomas M. Bargar, John K. Daniel
  • Patent number: 4584379
    Abstract: 4-[(4-Isoquinolinylmethyl)amino]benzoic acid derivatives useful as selective thromboxane synthetase inhibitors are described herein. The compounds are obtained from the appropriate 4-isoquinolinecarboxylic acid derivative and an aminobenzoic acid derivative. This gives the corresponding Schiff base which is then reduced to give the desired compounds.
    Type: Grant
    Filed: January 22, 1985
    Date of Patent: April 22, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Eugene R. Wagner
  • Patent number: 4581448
    Abstract: Fused tetracyclic compounds containing two thiophene rings, one pyridine ring and a triazine ring and which are useful as antiallergic agents are described herein. The compounds are prepared by the reaction of an appropriate substituted aminocarboxamine with sodium nitrite in an acid such as acetic acid.
    Type: Grant
    Filed: October 10, 1984
    Date of Patent: April 8, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Wright
  • Patent number: 4581455
    Abstract: (1H-Tetrazol-5-yl)tetrazolo[1,5-a]thienopyridines and related compounds which are useful as antiallergic agents are described herein. The compounds are prepared by the reaction of an appropriate halocyano-quinoline with ammonium chloride and an azide such as sodium azide in an inert solvent such as dimethylformamide.
    Type: Grant
    Filed: October 10, 1984
    Date of Patent: April 8, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Wright
  • Patent number: 4578464
    Abstract: 8-Methyl-1,2,4-triazolo[4,3-b]pyridazines having a hydroxyalkylamino substituent at the 6-position are described herein. The compounds involved are useful as bronchodilator agents and they are prepared by the reaction of 6-chloro-8-methyl-1,2,4-triazolo[4,3-b]-pyridazine with an appropriate amino alcohol.
    Type: Grant
    Filed: November 22, 1983
    Date of Patent: March 25, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Robert J. Cregge, John E. Coutant